Retatrutide

Description

Retatrutide is a novel triple-agonist peptide that simultaneously activates GIP, GLP-1, and glucagon receptors. This multi-receptor approach is studied for its potential in metabolic research, including appetite regulation, energy expenditure, and body composition. It represents the next generation of incretin-based compounds in preclinical investigation.

Product Specifications:

• Form: Lyophilized powder
• Purity: HPLC-verified
• Mechanism: Triple GIP/GLP-1/glucagon receptor agonist for metabolic research.
• Storage: Refrigerate 2-8°C.

For research use only.